{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:37:34Z","timestamp":1793151454153,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medizinische Fakult\u00e4t Heidelberg der Universit\u00e4t Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pre-Exposure Prophylaxis (PrEP) has demonstrated clinical efficacy in preventing HIV infection, yet its uptake remains low. This study, conducted in five PrEP implementing districts in Lesotho, examined factors motivating persons at risk of HIV infection to adopt or reject PrEP when offered freely.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In-depth interviews were undertaken with stakeholders directly engaged with PrEP policy (n\u2009=\u20095), program implementation (n\u2009=\u20094), and use (current PrEP users\u2009=\u200955, former PrEP users\u2009=\u200936, and PrEP decliners (n\u2009=\u20096)). Focus group discussions (n\u2009=\u200911, 105 total participants) were conducted with health staff directly providing HIV and PrEP services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Demand for PrEP was reported highest among those at greatest risk for HIV acquisition: those in serodiscordant relationships and\/or engaged in sex work. Culturally sensitive PrEP counseling was described as an opportunity to transfer knowledge, build trust, and address user concerns. Conversely, top-down counseling resulted in PrEP distrust and confusion about HIV status. Key motivations for PrEP uptake revolved around sustaining core social relationships,\u00a0desire for\u00a0safer conception, and caring for ailing\u00a0relatives. The decline of PrEP\u00a0initiation was driven by a combination of individual-level factors\u00a0(risk perception, perceived side effects, disbelief of the drug\u2019s efficacy and PrEP\u2019s daily pill regimen), societal factors\u00a0(lack of social support and HIV-related stigma),\u00a0and structural factors\u00a0related to PrEP access.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our\u00a0findings suggest strategies for effective national PrEP rollout and implementation include: (1) demand creation campaigns which highlight positive aspects of PrEP, while simultaneously addressing apprehensions for uptake; (2) strengthening health provider counseling capacity; and (3) addressing societal and structural HIV-related stigma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12981-023-00535-x","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T06:01:53Z","timestamp":1688623313000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Motivations for pre-exposure prophylaxis uptake and decline in an HIV-hyperendemic setting: findings from a qualitative implementation study in Lesotho"],"prefix":"10.1186","volume":"20","author":[{"given":"Joy J.","family":"Chebet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon A.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapiwa","family":"Tarumbiswa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hlalele","family":"Hlalele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chivimbiso","family":"Maponga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Mandara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacey","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halimatou","family":"Alaofe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Baernighausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Ehiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Geldsetzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Nichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"535_CR1","unstructured":"UNAIDS. In Danger: UNAIDS Global AIDS Update 2022. Geneva; 2022."},{"key":"535_CR2","unstructured":"Kates J, Wexler A, Lief E. Donor government funding for HIV in low- and middle-income countries: can we achieve an AIDS free generation?. 2019."},{"key":"535_CR3","doi-asserted-by":"publisher","first-page":"e629","DOI":"10.1016\/S2352-3018(20)30211-3","volume":"7","author":"BL Jewell","year":"2020","unstructured":"Jewell BL, Mudimu E, Stover J, ten Brink D, Phillips AN, Smith JA, et al. Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models. Lancet HIV. 2020;7:e629-40. https:\/\/doi.org\/10.1016\/S2352-3018(20)30211-3.","journal-title":"Lancet HIV"},{"key":"535_CR4","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","volume":"30","author":"VA Fonner","year":"2016","unstructured":"Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O\u2019Reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30:1973\u201383.","journal-title":"AIDS"},{"key":"535_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-019-0685-6","author":"VE Powell","year":"2019","unstructured":"Powell VE, Gibas KM, DuBow J, Krakower DS. Update on HIV preexposure prophylaxis: effectiveness, drug resistance, and risk compensation. Curr Infect Dis Rep. 2019. https:\/\/doi.org\/10.1007\/s11908-019-0685-6.","journal-title":"Curr Infect Dis Rep"},{"key":"535_CR6","unstructured":"World Health Organization. Guideline on When To Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. World Heal Organ. 2015. http:\/\/www.who.int\/hiv\/pub\/guidelines\/earlyrelease-arv\/en\/"},{"key":"535_CR7","unstructured":"PrEP Watch. PrEPWatch. 2023. www.prepwatch.org. Accessed 1 Jun 2023."},{"key":"535_CR8","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.19.7.21101","author":"F Cowan","year":"2016","unstructured":"Cowan F, Delany-Moretlwe S, Sanders EJ, Mugo NR, Guedou F, Alary M. PrEP implementation research in Africa: what is new? J Int AIDS Soc. 2016. https:\/\/doi.org\/10.7448\/IAS.19.7.21101.","journal-title":"J Int AIDS Soc"},{"key":"535_CR9","unstructured":"UNAIDS. Country factsheets: Lesotho. 2021."},{"key":"535_CR10","unstructured":"Government of Lesotho. National guidelines on the use of antiretroviral therapy for HIV prevention and treatment. 2016."},{"issue":"10","key":"535_CR11","doi-asserted-by":"publisher","first-page":"e0000762","DOI":"10.1371\/journal.pgph.0000762","volume":"2","author":"P Geldsetzer","year":"2022","unstructured":"Geldsetzer P, Chebet JJ, Tarumbiswa T, Phate-Lesihla R, Maponga C, Mandara E, et al. Knowledge and attitudes about HIV pre-exposure prophylaxis: evidence from in-depth interviews and focus group discussions with policy makers, healthcare providers, and end-users in Lesotho. PLOS Glob Public Health. 2022;2(10):e0000762. https:\/\/doi.org\/10.1371\/journal.pgph.0000762.","journal-title":"PLOS Glob Public Health"},{"key":"535_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1525\/maq.1997.11.2.147","volume":"11","author":"P Pelto","year":"1997","unstructured":"Pelto P, Pelto G. Studying knowledge, culture, and behavior in applied medical anthropology. Med Anthropol. 1997;11:147\u201363.","journal-title":"Med Anthropol"},{"key":"535_CR13","doi-asserted-by":"publisher","first-page":"e000837","DOI":"10.1136\/bmjgh-2018-000837","volume":"3","author":"SA McMahon","year":"2018","unstructured":"McMahon SA, Winch PJ. Systematic debriefing after qualitative encounters: an essential analysis step in applied qualitative research. BMJ Glob Heal. 2018;3:e000837. https:\/\/doi.org\/10.1136\/bmjgh-2018-000837.","journal-title":"BMJ Glob Heal"},{"key":"535_CR14","unstructured":"Development SS. ATLAS.ti. Berlin; 2009."},{"key":"535_CR15","doi-asserted-by":"publisher","unstructured":"Sila J, Larsen AM, Kinuthia J, Owiti G, Abuna F, Kohler PK, John-Stewart G, Pintye J. High awareness, yet low uptake, of pre-exposure prophylaxis among adolescent girls and young women within family planning clinics in Kenya. AIDS Patient care STDs. 2020;34(8):336\u201343. https:\/\/doi.org\/10.1089\/apc.2020.0037.","DOI":"10.1089\/apc.2020.0037"},{"key":"535_CR16","unstructured":"UNAIDS. Global AIDS update 2019: Communities at the centre. Geneva, Switzerland; 2019."},{"key":"535_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7448\/IAS.18.4.20227","volume":"18","author":"CL Celum","year":"2015","unstructured":"Celum CL, Delany-Moretlwe S, McConnell M, Van Rooyen H, Bekker LG, Kurth A, et al. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women. J Int AIDS Soc. 2015;18:1\u201310.","journal-title":"J Int AIDS Soc"},{"key":"535_CR18","first-page":"1","volume":"17","author":"AL Corneli","year":"2014","unstructured":"Corneli AL, McKenna K, Headley J, Ahmed K, Odhiambo J, Skhosana J, et al. A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya, and Pretoria. South Africa J Int AIDS Soc. 2014;17:1\u20138.","journal-title":"South Africa J Int AIDS Soc"},{"key":"535_CR19","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s10461-020-02780-x","volume":"24","author":"CS Camlin","year":"2020","unstructured":"Camlin CS, Koss CA, Getahun M, Owino L, Itiakorit H, Akatukwasa C, et al. Understanding demand for PrEP and early experiences of PrEP use among young adults in rural Kenya and Uganda: a qualitative study. AIDS Behav. 2020;24:2149\u201362. https:\/\/doi.org\/10.1007\/s10461-020-02780-x.","journal-title":"AIDS Behav"},{"key":"535_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/QAI.0000000000001567","volume":"77","author":"JT Price","year":"2018","unstructured":"Price JT, Rosenberg NE, Vansia D, Phanga T, Bhushan NL, Maseko B, et al. Predictors of HIV, HIV risk perception, and HIV worry among adolescent girls and young women in Lilongwe. Malawi J Acquir Immune Defic Syndr. 2018;77:53\u201363.","journal-title":"Malawi J Acquir Immune Defic Syndr"},{"key":"535_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0227632","volume":"15","author":"MM Gombe","year":"2020","unstructured":"Gombe MM, Cakouros BE, Ncube G, Zwangobani N, Mareke P, Mkwamba A, et al. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: qualitative perspectives of general population clients at high risk for HIV. PLoS One. 2020;15:1\u201318. https:\/\/doi.org\/10.1371\/journal.pone.0227632.","journal-title":"PLoS One"},{"key":"535_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25225","author":"E Nakku-Joloba","year":"2019","unstructured":"Nakku-Joloba E, Pisarski EE, Wyatt MA, Muwonge TR, Asiimwe S, Celum CL, et al. Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples. J Int AIDS Soc. 2019. https:\/\/doi.org\/10.1002\/jia2.25225.","journal-title":"J Int AIDS Soc"},{"key":"535_CR23","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1080\/13691058.2017.1309682","volume":"19","author":"E Govender","year":"2017","unstructured":"Govender E, Mansoor L, MacQueen K, Abdool Karim Q. Secrecy, empowerment and protection: positioning PrEP in KwaZulu-Natal South Africa. Cult Heal Sex. 2017;19:1268\u201385. https:\/\/doi.org\/10.1080\/13691058.2017.1309682.","journal-title":"Cult Heal Sex"},{"key":"535_CR24","doi-asserted-by":"publisher","first-page":"e582","DOI":"10.1016\/S2352-3018(20)30102-8","volume":"7","author":"J Pintye","year":"2020","unstructured":"Pintye J, Davey DLJ, Wagner AD, John-Stewart G, Baggaley R, Bekker LG, et al. Defining gaps in pre-exposure prophylaxis delivery for pregnant and post-partum women in high-burden settings using an implementation science framework. Lancet HIV. 2020;7:e582\u201392.","journal-title":"Lancet HIV"},{"key":"535_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0212271","volume":"14","author":"R Eakle","year":"2019","unstructured":"Eakle R, Bothma R, Bourne A, Gumede S, Motsosi K, Rees H. \u201cI am still negative\u201d: Female sex workers\u2019 perspectives on uptake and use of daily preexposure prophylaxis for HIV prevention in South Africa. PLoS One. 2019;14:1\u201317. https:\/\/doi.org\/10.1371\/journal.pone.0212271.","journal-title":"PLoS One"},{"key":"535_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jia2.25276","volume":"22","author":"CM Mayer","year":"2019","unstructured":"Mayer CM, Owaraganise A, Kabami J, Kwarisiima D, Koss CA, Charlebois ED, et al. Distance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda. J Int AIDS Soc. 2019;22:1\u20138.","journal-title":"J Int AIDS Soc"},{"key":"535_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12978-016-0263-4","volume":"14","author":"L Katirayi","year":"2017","unstructured":"Katirayi L, Chadambuka A, Muchedzi A, Ahimbisibwe A, Musarandega R, Woelk G, et al. Echoes of old HIV paradigms: Reassessing the problem of engaging men in HIV testing and treatment through women\u2019s perspectives. Reprod Health Reproduct Health. 2017;14:1\u201313.","journal-title":"Reprod Health Reproduct Health"},{"key":"535_CR28","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1080\/09540121.2015.1131972","volume":"28","author":"JJ Carroll","year":"2016","unstructured":"Carroll JJ, Ngure K, Heffron R, Curran K, Mugo NR, Baeten JM. Gendered differences in the perceived risks and benefits of oral PrEP among HIV-serodiscordant couples in Kenya. AIDS Care Psychol Socio Med Asp AIDS\/HIV. 2016;28:1000\u20136.","journal-title":"AIDS Care Psychol Socio Med Asp AIDS\/HIV"},{"key":"535_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2989\/16085906.2020.1727932","volume":"19","author":"L Mbewe","year":"2020","unstructured":"Mbewe L, Govender E. Male partners\u2019 influence on women\u2019s acceptance and use of PrEP products across two high HIV-burdened districts in South Africa. African J AIDS Res. 2020;19:93\u2013100. https:\/\/doi.org\/10.2989\/16085906.2020.1727932.","journal-title":"African J AIDS Res."},{"key":"535_CR30","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2020.1744507","author":"EM Irungu","year":"2020","unstructured":"Irungu EM, Ngure K, Mugwanya KK, Awuor M, Dollah A, Ongolly F, et al. \u201cNow that PrEP is reducing the risk of transmission of HIV, why then do you still insist that we use condoms?\u201d the condom quandary among PrEP users and health care providers in Kenya. AIDS Care. 2020. https:\/\/doi.org\/10.1080\/09540121.2020.1744507.","journal-title":"AIDS Care"},{"key":"535_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207650","author":"I Kambutse","year":"2018","unstructured":"Kambutse I, Igiraneza G, Ogbuagu O. Perceptions of HIV transmission and Preexposure prophylaxis among health care workers and community members in Rwanda. PLoS One. 2018. https:\/\/doi.org\/10.1371\/journal.pone.0207650.","journal-title":"PLoS One"},{"key":"535_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/COH.0000000000000224","volume":"11","author":"NR Mugo","year":"2016","unstructured":"Mugo NR, Ngure K, Kiragu M, Irungu E, Kilonzo N. PrEP for Africa: what we have learnt and what is needed to move to program implementation. Curr Opin HIV AIDS. 2016;11:80\u20136.","journal-title":"Curr Opin HIV AIDS"},{"key":"535_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11904-018-0385-0","volume":"15","author":"SA Golub","year":"2018","unstructured":"Golub SA. PrEP stigma: implicit and explicit drivers of disparity. Curr HIV\/AIDS Rep. 2018;15:190\u20137.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"535_CR34","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.2105\/AJPH.2015.302816","volume":"105","author":"SK Calabrese","year":"2015","unstructured":"Calabrese SK, Underhill K. How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize \u201ctruvada whores.\u201d Am J Public Health. 2015;105:1960\u20134.","journal-title":"Am J Public Health"},{"key":"535_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/09540121.2019.1653437","volume":"32","author":"K B\u00e4rnighausen","year":"2020","unstructured":"B\u00e4rnighausen K, Matse S, Hughey AB, Hettema A, B\u00e4rnighausen TW, McMahon SA. \u201cWe know this will be hard at the beginning, but better in the long term\u201d: understanding PrEP uptake in the general population in Eswatini. AIDS Care. 2020;32:267\u201373. https:\/\/doi.org\/10.1080\/09540121.2019.1653437.","journal-title":"AIDS Care"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-023-00535-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-023-00535-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-023-00535-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T06:08:29Z","timestamp":1688623709000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-023-00535-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["535"],"URL":"https:\/\/doi.org\/10.1186\/s12981-023-00535-x","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]},"assertion":[{"value":"15 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was received from the Lesotho Ministry of Health (ID03-2019) and Heidelberg University (S-865\/2018). All study participants provided informed consent as part of study enrollment procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}